Integrating clinical studies and Patient Support Programs(PSPs) for holistic rare disease care
In our latest expert guide, we explore the potential integration of clinical studies with patient support programs. A move which could enhance the depth and quality of your real-world data and give patients easier access to new life-changing treatments.
Detailing the advantages and challenges of this holistic approach, the article covers:
- The current challenges of rare disease clinical trials
- The key role of Early Access Programs and Observational Studies
- The benefits of Patient Support Programs
- The potential of a new holistic approach: integrating clinical studies and PSPs